Early improvement as a predictor of treatment response and remission in patients with schizophrenia: A pooled, post-hoc analysis from the asenapine development program

Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it?

(2012) Larry Alphs et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia

(2011) Stephen J Ruberg et al.   BMC Psychiatry

Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia

(2011) Kotaro Hatta et al.   SCHIZOPHRENIA RESEARCH

What’s Next After 50 Years of Psychiatric Drug Development

(2010) Thomas P. Laughren   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia

(2010) John M. Kane et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Does Clinical Judgment of Baseline Severity and Changes in Psychopathology Depend on the Patient Population?

(2010) Rebecca Schennach-Wolff et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis

(2010) Virginia L. Stauffer et al.   PSYCHIATRY RESEARCH

Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study

(2009) M. Jäger et al.   EUROPEAN PSYCHIATRY

Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia

(2009) Bruce J Kinon et al.   NEUROPSYCHOPHARMACOLOGY

Early- and Delayed Antipsychotic Response and Prediction of Outcome in 528 Severely Impaired Patients with Schizophrenia Treated with Amisulpride

(2009) M. Lambert et al.   PHARMACOPSYCHIATRY

Should the PANSS Be Rescaled?

(2009) M. Obermeier et al.   SCHIZOPHRENIA BULLETIN

Definitions of response and remission in schizophrenia: recommendations for their use and their presentation

(2008) S. Leucht et al.   ACTA PSYCHIATRICA SCANDINAVICA

How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

(2008) S Leucht et al.   MOLECULAR PSYCHIATRY

Predicting antipsychotic drug response – Replication and extension to six weeks in an international olanzapine study

(2008) Stefan Leucht et al.   SCHIZOPHRENIA RESEARCH

Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders

(2008) O AGID et al.   SCHIZOPHRENIA RESEARCH

Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia☆

(2008) B KINON et al.   SCHIZOPHRENIA RESEARCH

Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia

(2007) H. Ascher-Svanum et al.   SCHIZOPHRENIA BULLETIN

Extrapolation between measures of symptom severity and change: An examination of the PANSS and CGI

(2007) Stephen Z. Levine et al.   SCHIZOPHRENIA RESEARCH